| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.1B | $1.1B | $1.0B | $0.8B | $0.7B | $0.2B | — |
| Cost of Revenue | $0.4B | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.3B | $0.4B | $0.4B | $0.3B | $0.2B | $0.2B | $0.0B | $0.0B |
| EPS (Basic) | $1.46 | $1.73 | $1.82 | $1.29 | $1.10 | $0.85 | $0.22 | $0.26 |
| EPS (Diluted) | $1.46 | $1.72 | $1.82 | $1.29 | $1.09 | $0.85 | $0.22 | $0.26 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.6B | $6.4B | $6.2B | $6.3B | $6.5B | $4.8B | $4.0B | $3.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.0B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.0B |
| Total Liabilities | $3.9B | $3.4B | $3.3B | $3.4B | $3.5B | $2.7B | $2.2B | $2.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.7B | $2.9B | $2.8B | $2.8B | $2.9B | $1.8B | $1.8B | $1.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.6B | $0.6B | $0.6B | $0.4B | $0.4B | $0.3B | $0.3B |
| Investing Cash Flow | $-0.6B | $-0.2B | $-0.1B | $-0.0B | $-1.9B | $-0.5B | $-0.4B | $-0.3B |
| Capital Expenditures | — | — | — | — | — | — | $0.1B | $0.2B |
| Financing Cash Flow | $-0.1B | $-0.4B | $-0.5B | $-0.5B | $1.4B | $0.1B | $0.1B | $0.0B |